# Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)

> **NCT06305676** · — · RECRUITING · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 400 (estimated)

## Conditions studied

- Oropharyngeal Cancer
- HPV-Related Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** combined HPV 16 DNA and host gene methylation oral biomarker panel

## Key facts

- **NCT ID:** NCT06305676
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-22
- **Primary completion:** 2029-01
- **Final completion:** 2029-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06305676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06305676, "Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06305676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*